...Biosciences Inc. (San Diego, Calif.), formerly known as Precision IBD Inc. McKenna was president at Salix Pharmaceuticals Ltd....

...modulator in Salix, two years after Biogen decided to return its rights to the compound. Salix Pharmaceuticals Ltd....
...receives an undisclosed upfront payment, and is eligible for development and regulatory milestones, plus royalties. Salix...
...from University of California Los Angeles (see "Salix Licenses New NASH Target from UCLA" ). Salix...

...with a license from UCLA to a compound against a new target in the space. Salix Pharmaceuticals Ltd....
...non-alcoholic steatohepatitis, non-alcoholic fatty liver disease and other gastrointestinal and liver diseases. The program is Salix's...
...showed that activating ADCYAP1R1 increased satiety and lean mass while suppressing appetite and fat accumulation. Salix...

...and general counsel, a newly created position. He was SVP, head of legal branded Rx (Salix...

...The Salix Pharmaceuticals Ltd. subsidiary of Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) and partner Norgine B.V. (Amsterdam, the...
...an NDA for Plenvu (NER1006) for bowel cleansing. The new PDUFA date is May 13. Salix...

...TSX:VRX; NYSE:VRX). The IPR petition was filed by generics company GeneriCo LLC (St. Louis, Mo.). Salix Pharmaceuticals Ltd....

...NYSE:ABBV) acquired Pharmacyclics Inc. for $21 billion; and Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) acquired Salix Pharmaceuticals Ltd....

...to $23.86 on Tuesday after media reports said it was discussing a sale of its Salix...
...has held discussions about "various divestitures including but not limited to Salix." Since Valeant acquired Salix...
...its stock closed at $173.26 in New York (see BioCentury Extra, March 16, 2015) . Chris Lieu Salix Pharmaceuticals Ltd. Valeant...

...mu opioid receptor (MOR; OPRM1 ) antagonist, excluding Japan, through its 2015 acquisition of Salix Pharmaceuticals Ltd. Salix...

...4Q16. Pharming granted Santarus Inc. rights to the product in 2010. Santarus was acquired by Salix Pharmaceuticals Ltd....